Weight-loss pill passes important safety trial
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, with AstraZeneca revealing “encouraging data” out of its Phase I study of its obesity and diabetes drug AZD5004. In a presentation at the ObesityWeek conference in San Antonio this week, the UK pharmaceutical […]
